Hepatitis B includes acute hepatitis B and chronic hepatitis B. More than 90% of adults with acute hepatitis B can be cleared of the virus, while chronic hepatitis B is not yet curable and can only be inhibited by antiviral treatment.
Chronic viral hepatitis B is a kind of infectious disease caused by hepatitis B virus (HBV) infection, which leads to liver function abnormality, liver fibrosis and other infectious diseases.HBV is mainly transmitted through mother-to-child, blood and sexual contact.HBV doesn’t kill the liver cells directly, but through the immune response to lead to hepatocyte damage and inflammation and necrosis, which will gradually progress to liver fibrosis, cirrhosis and even liver cancer.
At present, chronic viral hepatitis B is mainly treated by antiviral therapy, such as tenofovir, entecavir, etc., and the use of some hepatoprotective and liver enzyme-lowering drugs, such as hepatoprotective tablets, etc., to control the condition and delay the progression of the disease, but can not be eradicated from the HBV virus.
Drugs need to follow the doctor’s instructions for rational application.